{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:56:41Z","timestamp":1793321801078,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This study was partially supported by PRIN (No. 2020FYCCE3) of the Italian Ministry of University and Research (MUR)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11102-026-01674-w","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:53:30Z","timestamp":1776261210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Vertebral fractures may occur early in the history of Cushing disease associating with male gender and degree of cortisol secretion"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6117-0081","authenticated-orcid":false,"given":"Luigi","family":"di Filippo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Frara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Terenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Menotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Mortini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giustina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"12","key":"1674_CR1","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847\u2013875. https:\/\/doi.org\/10.1016\/S2213-8587(21)00235-7","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"1674_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11892-017-0860-9","volume":"17","author":"G Mazziotti","year":"2017","unstructured":"Mazziotti G, Formenti AM, Frara S, Maffezzoni F, Doga M, Giustina A (2017) Diabetes in Cushing Disease. Curr Diab Rep 17(5):32. https:\/\/doi.org\/10.1007\/s11892-017-0860-9","journal-title":"Curr Diab Rep"},{"issue":"4","key":"1674_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11102-005-1051-2","volume":"7","author":"T Mancini","year":"2004","unstructured":"Mancini T, Doga M, Mazziotti G, Giustina A (2004) Cushing\u2019s syndrome and bone. Pituitary 7(4):249\u2013252. https:\/\/doi.org\/10.1007\/s11102-005-1051-2","journal-title":"Pituitary"},{"issue":"12","key":"1674_CR4","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1210\/jc.2003-030871","volume":"88","author":"G Arnaldi","year":"2003","unstructured":"Arnaldi G, Angeli A, Atkinson AB et al (2003) Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement. J Clin Endocrinol Metab 88(12):5593\u20135602. https:\/\/doi.org\/10.1210\/jc.2003-030871","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1674_CR5","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s11102-022-01252-w","volume":"25","author":"S Frara","year":"2022","unstructured":"Frara S, di Filippo L, Doga M, Loli P, Casanueva FF, Giustina A (2022) Novel approaches to bone comorbidity in Cushing\u2019s disease: an update. Pituitary 25(5):754\u2013759. https:\/\/doi.org\/10.1007\/s11102-022-01252-w","journal-title":"Pituitary"},{"issue":"2","key":"1674_CR6","doi-asserted-by":"publisher","first-page":"101515","DOI":"10.1016\/j.beem.2021.101515","volume":"35","author":"S Frara","year":"2021","unstructured":"Frara S, Allora A, di Filippo L et al (2021) Osteopathy in mild adrenal Cushing\u2019s syndrome and Cushing disease. Best Pract Res Clin Endocrinol Metab 35(2):101515. https:\/\/doi.org\/10.1016\/j.beem.2021.101515","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"1674_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s40618-024-02450-y","volume":"48","author":"R Giordano","year":"2025","unstructured":"Giordano R, Parasiliti Caprino M, Loli P, Giustina A (2025) Screening for endogenous hypercortisolism in patients with osteoporosis and fractures: why, when and how. J Endocrinol Invest 48(Suppl 1):23\u201331. https:\/\/doi.org\/10.1007\/s40618-024-02450-y","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"1674_CR8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.tem.2006.03.009","volume":"17","author":"G Mazziotti","year":"2006","unstructured":"Mazziotti G, Angeli A, Bilezikian JP, Canalis E, Giustina A (2006) Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab 17(4):144\u2013149. https:\/\/doi.org\/10.1016\/j.tem.2006.03.009","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"1674_CR9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s12020-024-03784-6","volume":"85","author":"L di Filippo","year":"2024","unstructured":"di Filippo L, Bilezikian JP, Canalis E, Terenzi U, Giustina A (2024) New insights into the vitamin D\/PTH axis in endocrine-driven metabolic bone diseases. Endocrine 85(3):1007\u20131019. https:\/\/doi.org\/10.1007\/s12020-024-03784-6","journal-title":"Endocrine"},{"issue":"7 Suppl","key":"1674_CR10","first-page":"16","volume":"33","author":"R Carpinteri","year":"2010","unstructured":"Carpinteri R, Porcelli T, Mejia C et al (2010) Glucocorticoid-induced osteoporosis and parathyroid hormone. J Endocrinol Invest 33(7 Suppl):16\u201321","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"1674_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s12020-016-1146-8","volume":"54","author":"G Mazziotti","year":"2016","unstructured":"Mazziotti G, Formenti AM, Adler RA et al (2016) Glucocorticoid-induced osteoporosis: pathophysiological role of GH\/IGF-I and PTH\/VITAMIN D axes, treatment options and guidelines. Endocrine 54(3):603\u2013611. https:\/\/doi.org\/10.1007\/s12020-016-1146-8","journal-title":"Endocrine"},{"issue":"10","key":"1674_CR12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.amjmed.2010.02.028","volume":"123","author":"G Mazziotti","year":"2010","unstructured":"Mazziotti G, Canalis E, Giustina A (2010) Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med 123(10):877\u2013884. https:\/\/doi.org\/10.1016\/j.amjmed.2010.02.028","journal-title":"Am J Med"},{"issue":"8","key":"1674_CR13","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s40618-020-01496-y","volume":"44","author":"T Apayd\u0131n","year":"2021","unstructured":"Apayd\u0131n T, Yavuz DG (2021) Assessment of non-traumatic vertebral fractures in Cushing\u2019s syndrome patients. J Endocrinol Invest 44(8):1767\u20131773. https:\/\/doi.org\/10.1007\/s40618-020-01496-y","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"1674_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/cen.13743","volume":"89","author":"H Vinolas","year":"2018","unstructured":"Vinolas H, Grouthier V, Mehsen-Cetre N et al (2018) Assessment of vertebral microarchitecture in overt and mild Cushing\u2019s syndrome using trabecular bone score. Clin Endocrinol (Oxf) 89(2):148\u2013154. https:\/\/doi.org\/10.1111\/cen.13743","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1674_CR15","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3389\/fendo.2019.00580","volume":"10","author":"LHA Broersen","year":"2019","unstructured":"Broersen LHA, van Haalen FM, Kienitz T et al (2019) Sex Differences in Presentation but Not in Outcome for ACTH-Dependent Cushing\u2019s Syndrome. Front Endocrinol (Lausanne) 10:580 Published 2019 Aug 30. https:\/\/doi.org\/10.3389\/fendo.2019.00580","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1674_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12020-019-02034-4","volume":"67","author":"F Ferra\u00f9","year":"2020","unstructured":"Ferra\u00f9 F, Giovinazzo S, Messina E et al (2020) High bone marrow fat in patients with Cushing\u2019s syndrome and vertebral fractures. Endocrine 67(1):172\u2013179. https:\/\/doi.org\/10.1007\/s12020-019-02034-4","journal-title":"Endocrine"},{"key":"1674_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11657-015-0244-1","volume":"10","author":"ZE Belaya","year":"2015","unstructured":"Belaya ZE, Hans D, Rozhinskaya LY et al (2015) The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing\u2019s syndrome. Arch Osteoporos 10:44. https:\/\/doi.org\/10.1007\/s11657-015-0244-1","journal-title":"Arch Osteoporos"},{"issue":"2","key":"1674_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12020-023-03318-6","volume":"80","author":"F Ferra\u00f9","year":"2023","unstructured":"Ferra\u00f9 F, Giovinazzo S, Alessi Y et al (2023) Trabecular bone score, bone marrow fat and vertebral fractures in cushing syndrome. Endocrine 80(2):441\u2013447. https:\/\/doi.org\/10.1007\/s12020-023-03318-6","journal-title":"Endocrine"},{"issue":"3","key":"1674_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1530\/EJE-07-0137","volume":"157","author":"L Tauchmanov\u00e0","year":"2007","unstructured":"Tauchmanov\u00e0 L, Pivonello R, De Martino MC et al (2007) Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism. Eur J Endocrinol 157(3):359\u2013366. https:\/\/doi.org\/10.1530\/EJE-07-0137","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1674_CR20","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1210\/jc.2005-0582","volume":"91","author":"L Tauchmanov\u00e0","year":"2006","unstructured":"Tauchmanov\u00e0 L, Pivonello R, Di Somma C et al (2006) Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status. J Clin Endocrinol Metab 91(5):1779\u20131784. https:\/\/doi.org\/10.1210\/jc.2005-0582","journal-title":"J Clin Endocrinol Metab"},{"key":"1674_CR21","doi-asserted-by":"publisher","unstructured":"di Filippo L, Acanfora M, Bolamperti S, Terenzi U, Bonomo M, Giustina A (2025) Osteometabolic complications in patients with secreting pituitary adenomas: Is there an impact of gender?. Pituitary https:\/\/doi.org\/10.1007\/s11102-026-01667-9","DOI":"10.1007\/s11102-026-01667-9"},{"issue":"11","key":"1674_CR22","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00198-004-1616-3","volume":"15","author":"M Minetto","year":"2004","unstructured":"Minetto M, Reimondo G, Osella G, Ventura M, Angeli A, Terzolo M (2004) Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing\u2019s syndrome. Osteoporos Int 15(11):855\u2013861. https:\/\/doi.org\/10.1007\/s00198-004-1616-3","journal-title":"Osteoporos Int"},{"issue":"1","key":"1674_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1507\/endocrj.50.1","volume":"50","author":"N Ohmori","year":"2003","unstructured":"Ohmori N, Nomura K, Ohmori K, Kato Y, Itoh T, Takano K (2003) Osteoporosis is more prevalent in adrenal than in pituitary Cushing\u2019s syndrome. Endocr J 50(1):1\u20137. https:\/\/doi.org\/10.1507\/endocrj.50.1","journal-title":"Endocr J"},{"issue":"2","key":"1674_CR24","doi-asserted-by":"publisher","first-page":"2282183","DOI":"10.1080\/07853890.2023.2282183","volume":"55","author":"H Sun","year":"2023","unstructured":"Sun H, Wu C, Hu B, Xie G (2023) High prevalence of vertebral fractures associated with preoperative cortisol levels in patients with recent diagnosis of Cushing disease. Ann Med 55(2):2282183. https:\/\/doi.org\/10.1080\/07853890.2023.2282183","journal-title":"Ann Med"},{"issue":"5","key":"1674_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrendo.2013.5","volume":"9","author":"G Mazziotti","year":"2013","unstructured":"Mazziotti G, Giustina A (2013) Glucocorticoids and the regulation of growth hormone secretion. Nat Rev Endocrinol 9(5):265\u2013276. https:\/\/doi.org\/10.1038\/nrendo.2013.5","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"1674_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.beem.2017.03.002","volume":"31","author":"AM Formenti","year":"2017","unstructured":"Formenti AM, Maffezzoni F, Doga M, Mazziotti G, Giustina A (2017) Growth hormone deficiency in treated acromegaly and active Cushing\u2019s syndrome. Best Pract Res Clin Endocrinol Metab 31(1):79\u201390. https:\/\/doi.org\/10.1016\/j.beem.2017.03.002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"7","key":"1674_CR27","doi-asserted-by":"publisher","first-page":"e2121","DOI":"10.1210\/clinem\/dgaf191","volume":"110","author":"M Tenuta","year":"2025","unstructured":"Tenuta M, Hasenmajer V, Gianfrilli D, Isidori AM (2025) Testosterone and Male Bone Health: A Puzzle of Interactions. J Clin Endocrinol Metab 110(7):e2121\u2013e2135. https:\/\/doi.org\/10.1210\/clinem\/dgaf191","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1674_CR28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12020-011-9486-x","volume":"40","author":"G Mazziotti","year":"2011","unstructured":"Mazziotti G, Gola M, Bianchi A et al (2011) Influence of diabetes mellitus on vertebral fractures in men with acromegaly. Endocrine 40(1):102\u2013108. https:\/\/doi.org\/10.1007\/s12020-011-9486-x","journal-title":"Endocrine"},{"issue":"5","key":"1674_CR29","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW et al (2008) The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93(5):1526\u20131540. https:\/\/doi.org\/10.1210\/jc.2008-0125","journal-title":"J Clin Endocrinol Metab"},{"issue":"10444","key":"1674_CR30","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/S0140-6736(24)00342-8","volume":"403","author":"M Fleseriu","year":"2024","unstructured":"Fleseriu M, Christ-Crain M, Langlois F, Gadelha M, Melmed S, Hypopituitarism (2024) Lancet 403(10444):2632\u20132648. https:\/\/doi.org\/10.1016\/S0140-6736(24)00342-8","journal-title":"Lancet"},{"issue":"12","key":"1674_CR31","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1007\/s40618-022-01859-7","volume":"45","author":"AM Isidori","year":"2022","unstructured":"Isidori AM, Aversa A, Calogero A et al (2022) Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE). J Endocrinol Invest 45(12):2385\u20132403. https:\/\/doi.org\/10.1007\/s40618-022-01859-7","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"1674_CR32","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S2213-8587(24)00199-2","volume":"12","author":"NL De Silva","year":"2024","unstructured":"De Silva NL, Papanikolaou N, Grossmann M et al (2024) Male hypogonadism: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol 12(10):761\u2013774. https:\/\/doi.org\/10.1016\/S2213-8587(24)00199-2","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"1674_CR33","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Min Res 8(9):1137\u20131148. https:\/\/doi.org\/10.1002\/jbmr.5650080915","journal-title":"J Bone Min Res"},{"issue":"9","key":"1674_CR34","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00198-008-0832-7","volume":"20","author":"S Kerkeni","year":"2009","unstructured":"Kerkeni S, Kolta S, Fechtenbaum J, Roux C (2009) Spinal deformity index (SDI) is a good predictor of incident vertebral fractures. Osteoporos Int 20(9):1547\u20131552. https:\/\/doi.org\/10.1007\/s00198-008-0832-7","journal-title":"Osteoporos Int"},{"issue":"6","key":"1674_CR35","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s11102-024-01427-7","volume":"27","author":"A Zdrojowy-We\u0142na","year":"2024","unstructured":"Zdrojowy-We\u0142na A, Stachowska B, Bolanowski M (2024) Cushing\u2019s disease and bone. Pituitary 27(6):837\u2013846. https:\/\/doi.org\/10.1007\/s11102-024-01427-7","journal-title":"Pituitary"},{"issue":"3","key":"1674_CR36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/cen.12299","volume":"80","author":"M Zilio","year":"2014","unstructured":"Zilio M, Barbot M, Ceccato F et al (2014) Diagnosis and complications of Cushing\u2019s disease: gender-related differences. Clin Endocrinol (Oxf) 80(3):403\u2013410. https:\/\/doi.org\/10.1111\/cen.12299","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1674_CR37","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1210\/jc.2002-021518","volume":"88","author":"F Pecori Giraldi","year":"2003","unstructured":"Pecori Giraldi F, Moro M, Cavagnini F, Study Group on the Hypothalamo-Pituitary-Adrenal Axis of the Italian Society of Endocrinology (2003) Gender-related differences in the presentation and course of Cushing\u2019s disease. J Clin Endocrinol Metab 88(4):1554\u20131558. https:\/\/doi.org\/10.1210\/jc.2002-021518","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1674_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5144\/0256-4947.2024.55","volume":"44","author":"BF Alqeeq","year":"2024","unstructured":"Alqeeq BF, Ayyad M, Almadhoun WJ et al (2024) Sex-related differences in Cushing\u2019s disease: a systematic review and meta-analysis. Ann Saudi Med 44(1):55\u201365. https:\/\/doi.org\/10.5144\/0256-4947.2024.55","journal-title":"Ann Saudi Med"},{"issue":"4","key":"1674_CR39","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1210\/er.2018-00005","volume":"39","author":"G Mazziotti","year":"2018","unstructured":"Mazziotti G, Frara S, Giustina A (2018) Pituitary Diseases and Bone. Endocr Rev 39(4):440\u2013488. https:\/\/doi.org\/10.1210\/er.2018-00005","journal-title":"Endocr Rev"},{"issue":"4","key":"1674_CR40","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.bone.2009.06.006","volume":"45","author":"T Mancini","year":"2009","unstructured":"Mancini T, Mazziotti G, Doga M et al (2009) Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. Bone 45(4):784\u2013788. https:\/\/doi.org\/10.1016\/j.bone.2009.06.006","journal-title":"Bone"},{"issue":"4","key":"1674_CR41","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/cen.12812","volume":"83","author":"CV dos Santos","year":"2015","unstructured":"dos Santos CV, Vieira Neto L, Madeira M et al (2015) Bone density and microarchitecture in endogenous hypercortisolism. Clin Endocrinol (Oxf) 83(4):468\u2013474. https:\/\/doi.org\/10.1111\/cen.12812","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"1674_CR42","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s11102-020-01041-3","volume":"23","author":"L di Filippo","year":"2020","unstructured":"di Filippo L, Doga M, Resmini E, Giustina A (2020) Hyperprolactinemia and bone. Pituitary 23(3):314\u2013321. https:\/\/doi.org\/10.1007\/s11102-020-01041-3","journal-title":"Pituitary"},{"issue":"9","key":"1674_CR43","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/BF03349263","volume":"31","author":"A Giustina","year":"2008","unstructured":"Giustina A, Barkan A, Chanson P et al (2008) Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults. J Endocrinol Invest 31(9):820\u2013838. https:\/\/doi.org\/10.1007\/BF03349263","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"1674_CR44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.tem.2023.01.006","volume":"34","author":"MM Uygur","year":"2023","unstructured":"Uygur MM, Frara S, di Filippo L, Giustina A (2023) New tools for bone health assessment in secreting pituitary adenomas. Trends Endocrinol Metab 34(4):231\u2013242. https:\/\/doi.org\/10.1016\/j.tem.2023.01.006","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"1674_CR45","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000375450","volume":"103","author":"KM Claessen","year":"2016","unstructured":"Claessen KM, Mazziotti G, Biermasz NR, Giustina A (2016) Bone and Joint Disorders in Acromegaly. Neuroendocrinology 103(1):86\u201395. https:\/\/doi.org\/10.1159\/000375450","journal-title":"Neuroendocrinology"},{"issue":"19","key":"1674_CR46","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMra2409076","volume":"393","author":"A Giustina","year":"2025","unstructured":"Giustina A, Colao A, Acromegaly (2025) N Engl J Med 393(19):1926\u20131939. https:\/\/doi.org\/10.1056\/NEJMra2409076","journal-title":"N Engl J Med"},{"issue":"2","key":"1674_CR47","doi-asserted-by":"publisher","first-page":"e602","DOI":"10.1210\/clinem\/dgaa738","volume":"106","author":"L di Filippo","year":"2021","unstructured":"di Filippo L, Formenti AM, Doga M, Pedone E, Rovere-Querini P, Giustina A (2021) Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes. J Clin Endocrinol Metab 106(2):e602\u2013e614. https:\/\/doi.org\/10.1210\/clinem\/dgaa738","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1674_CR48","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11102-023-01345-0","volume":"26","author":"A Giustina","year":"2023","unstructured":"Giustina A, Uygur MM, Frara S et al (2023) Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers. Pituitary 26(5):583\u2013596. https:\/\/doi.org\/10.1007\/s11102-023-01345-0","journal-title":"Pituitary"},{"key":"1674_CR49","doi-asserted-by":"publisher","unstructured":"Giustina A, Uygur MM, Frara S et al (2025) Medical management pathways for Cushing\u2019s disease in pituitary tumors centers of excellence (PTCOEs). Pituitary 28(1):23. Published 2025 Jan 29. https:\/\/doi.org\/10.1007\/s11102-024-01485-x","DOI":"10.1007\/s11102-024-01485-x"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01674-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01674-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01674-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:49:17Z","timestamp":1782409757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01674-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1674"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01674-w","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LDF is partially supported by Glucorticoid induced Osteoporosis Skeletal Endocrinology Group (GIOSEG) research grant. SF received research grant to Institution from Abiogen Pharma, consultancy and speaker fees from Ipsen, Novartis and Pfizer, took part in advisory boards from Recordati and Novo Nordisk. LDF is Associate Editor of Pituitary. AG is Editor in Chief of Pituitary. The other Authors declare that they have no conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}